A. Denys et al., DISTRIBUTION OF CYCLOPHILIN B-BINDING SITES IN THE SUBSETS OF HUMAN PERIPHERAL-BLOOD LYMPHOCYTES, Immunology, 91(4), 1997, pp. 609-617
Cyclophilin B (CyPB) is a cyclosporin A (CsA)-binding protein, mainly
associated with the secretory pathway and released in biological fluid
s. We have recently demonstrated that both free CyPB and CyPB-CsA comp
lex specifically bind to peripheral blood T lymphocytes and are intern
alized. These results suggest that CyPB might promote the targeting of
the drug into sensitive cells. Peripheral blood lymphocytes are subdi
vided in several populations according to their biological functions a
nd sensitivity to CsA. We have investigated the binding of CyPB to the
se different subsets using a CyPB derivatized by fluorescein through i
ts single cysteine which retains its binding properties. We have confi
rmed that only T cells were involved in the interaction with CyPB. The
ligand binding was found to be heterogeneously distributed on the dif
ferent T-cell subsets and surface-bound CyPB was mainly associated wit
h the CD4-positive cells. No significant difference was noted between
the CD45RA and CD45RO subsets, demonstrating that CyPB-binding sites w
ere equally distributed between native and memory T cells. CD3 stimula
tion of T lymphocytes led to a decrease in the CyPB-binding capacity,
that may be explained by a downregulation of the CyPB-receptor express
ion upon T-cell activation. Finally, we demonstrated thar CyPB-recepto
r-positive cells, isolated on CyPB sulphydryl-coupled affinity matrice
s, are more sensitive to CyPB-complexed CsA than mixed peripheral bloo
d lymphocytes, suggesting thar CyPB potentiates CsA activity through t
he binding of the complex. Taken together, our results demonstrate tha
t CyPB-binding sites are mainly associated with resting cells of the h
elper T lymphocyte, and that CyPB might modulate the distribution of C
sA through the drug targeting to sensitive cells.